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Abstract
Background: Schistosomiasis is a major socio-economic and public health problem in many sub-Saharan African
countries. After large mass drug administration (MDA) campaigns, prevalence of infection rapidly returns to pre-
treatment levels. The traditional egg-based diagnostic for schistosome infections, Kato-Katz, is being substituted in
many settings by circulating antigen recognition-based diagnostics, usually the point-of-care circulating cathodic
antigen test (CCA). The relationship between these diagnostics is poorly understood, particularly after treatment in
both drug-efficacy studies and routine monitoring.
Results: We created a model of schistosome infections to better understand and quantify the relationship between
these two egg- and adult worm antigen-based diagnostics. We focused particularly on the interpretation of “trace”
results after CCA testing. Our analyses suggest that CCA is generally a better predictor of prevalence, particularly
after treatment, and that trace CCA results are typically associated with truly infected individuals.
Conclusions: Even though prevalence rises to pre-treatment levels only six months after MDAs, our model
suggests that the average intensity of infection is much lower, and is probably in part due to a small burden of
surviving juveniles from when the treatment occurred. This work helps to better understand CCA diagnostics and
the interpretation of post-treatment prevalence estimations.
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Background
Schistosomiasis is a major public health and socio-
economic problem in many sub-Saharan African coun-
tries, with estimates of 240 million people infected [1].
The current strategy to control morbidity is based on
mass drug administrations (MDA) with the anthelmintic
drug praziquantel. However, this does not prevent re-
infection, which can be very rapid, with prevalence often
reported to quickly return to pre-treatment levels [2–5].
The main diagnostic tool currently used to evaluate
Schistosoma mansoni prevalence and intensity of infection
is the Kato-Katz thick smear technique (KK) [6], which
measures the number of parasite eggs in one (or more)
41.7 mg smears taken from a stool sample. KK has a very
high specificity (∼100%), and gives a quantitative measure
of the level of infection, the egg count, which is positively
correlated with disease burden. However, it has some disad-
vantages, including large day-to-day variation in egg out-
puts and readings [7–9] and low sensitivity at low levels of
infection. This low sensitivity is due to fewer eggs being
present at low intensities of infection and therefore less
likely to be within the small sample of faeces [5, 10–13].
Eggs are still excreted after recent treatment, and are viable;
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with heavy excretions that can occur over a week post-
treatment [5].
The “point-of-care” circulating cathodic antigen test
(CCA) that measures schistosomal antigen in the urine
is an alternative technique to evaluate presence of infec-
tion. These are regurgitated gut antigens from feeding
worms, which might include juveniles. There are no
soluble egg antigen (SEA) tests available to specifically
measure egg presence. CCA therefore measures antigens
in active worm infections that disappear from the body
within 24 to 48 h of clearing the infection [14]. These
assays are commercially available, and are now being
used for countrywide mapping of the prevalence of
schistosomiasis [15–17]. CCA has a higher sensitivity
than KK, particularly at low intensity of infection, but
there are some indications that specificity might not be
100% [5, 13, 18, 19]. One of the challenges of estimating
specificity is the lack of an accurate “gold standard”
against which CCA can be evaluated [19–21]. CCA pos-
sesses other limitations, such as how to interpret “trace”
results, which is believed to represent a large proportion
of true positives although again remains under debate and
may vary across differing endemicity level areas, with
urine concentration and between test readers [21, 22].
Despite several community- and national level-based
studies, the relationship between KK and CCA diagnosis
is still not well understood. Latent Markov models [23],
latent class analyses [13, 24] and generalized linear mixed
models [15] have been used to help elucidate this and ad-
dress the issues associated with “trace” readings. However,
these studies have focused on data pre-treatment and
these relationships may become more complex and par-
ticularly important after recent treatment.
In this paper, we combined the information from KK
and CCA pre-treatment, one month post- and six months
post-treatment in a high endemic S. mansoni area, to cre-
ate a mathematical model of the relationship between the
two diagnostics at an individual level. We fitted this model
using a Bayesian framework and estimated true underlying
schistosome prevalence. We then used the model to simu-
late populations and sample KK and CCA diagnostics,
with the aim of comparing the error in the estimation of
prevalence using either CCA or KK (with different num-
bers of stool samples analysed).
Methods
Data
The dataset used in this manuscript was sourced from a
longitudinal study in three primary schools in Mayuge
District, Uganda, a highly endemic area on the shores of
Lake Victoria [5]. The students, between the ages of 6
and 12, were sampled at baseline (before treatment), one
month after treatment and six months after treatment.
At each sampling time, KK was performed in duplicate
over three days as well as one CCA from a single urine
sample. The number of individuals tested was 364, al-
though there are missing data in some entries, with
some individuals not having all six KK results, these can
be inferred by the model (see below). More information
on the sample collection and processing details is out-
lined by Lamberton et al. [5].
Base model
We created a mathematical model of S. mansoni infec-
tion in humans, where we assumed a gamma distribu-
tion of true intensity of infection across the infected
population combined with a negative binomial distribu-
tion of error in these estimations at each time-point, in a
similar fashion to the zero-inflated model developed in
Atlija, Prada et al. [25], see Additional file 1 for a de-
tailed model description. This framework allows discrim-
ination between infected and uninfected individuals,
and we can estimate infection status based on the in-
formation we have from each individual’s diagnostics
results. Individuals with undetectable levels of infec-
tion can potentially be assigned to either the infected
or uninfected group. We can therefore define individ-
uals’ infectious status as
Statusi;t ¼ 0 uninfected or undetectable infection
1 infected

where Status = 0 means that the individual is uninfected
or with undetectable levels of infection, while Status = 1
means that the individual is infected (at either detectable
or undetectable levels), for each individual i at time t.
The true prevalence at each time-point t, is the propor-
tion of individuals with Status = 1, henceforth referred
to as Pt.
Each infected individual has an intensity of infection,
λi,t, drawn from a gamma distribution of intensity across
the population, with shape, st, and rate, rt, parameters
being estimated in the model at each time-point t,
λi;t ¼ Gamma st ; rtð Þ
Kato-Katz, like any other method for obtaining faecal
egg counts is susceptible to measurement error, particu-
larly at low levels of infection. Unlike previous work
where a Poisson distribution was used [25], we instead
employed a negative binomial distribution, as the vari-
ance in the counts is higher than the mean [26, 27], with
an over-dispersion parameter ω. Moreover, uninfected
individuals by definition do not have schistosomes,
therefore cannot have KK counts different from zero;
based on the individuals’ status estimated above, the KK
diagnostic for individual i, at time t, for the repeated
count c would be:
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KKi;t;c ¼
0 If Statusi;t ¼ 0
NegBinomial λi;t ;ω
 
If Statusi;t ¼ 1
(
Similarly, the individual’s status will determine possible
CCA test outcomes and since the CCA test used in the
field is a semi-quantitative diagnostic, with possible
values of negative (−), trace, positive (+), double positive
(+ +) and triple positive (+ + +), we converted them into
0, 1, 2, 3 and 4, respectively. For infected individuals, we
calculatedPCCAi;t , which is a value between zero and one,
that depends on the estimated intensity of infection λi, t,
via a logistic function with model parameters k1 and k2
being estimated
PCCAi;t ¼
1
1þ e−k1 λi;t−k2ð Þ
We then used thePCCAi;t value to simulate the CCA diag-
nostic outcome with a binomial distribution of n = 4, such
that highly infected individuals are more likely to be diag-
nosed positive [or (+ +)/(+ + +)]. On the other hand, unin-
fected individuals, if the specificity of the diagnostic was
100%, should have negative CCA. Because the specificity
is lower, we allowed for some uninfected individuals to
have trace results in the diagnostic, with a probabilityPTr;
the CCA diagnostic would therefore be:
KKi;t;c ¼
Bernouilli PTrð Þ If Statusi;t ¼ 0
Binomial n ¼ 4; p ¼ PCCAi;t
 
If Statusi;t ¼ 1
8<
:
This particular framework assumes that KK specificity
is 100%, and thus uninfected individuals must have zero
eggs, as well as limiting the possible CCA results for un-
infected individuals to either (−) or trace. The true
prevalence estimate (i.e. proportion of infected individ-
uals, Pt) can then be compared to the KK and CCA
prevalence from the raw data.
The model was fitted to all three time-points concur-
rently. We forced the mean intensity of infection (mean
of the gamma distribution) for the time-point one
month after treatment (t = 2) to be lower than at base-
line (before treatment, t = 1) and at six months post-
treatment (t = 3) such that
s2
r2
<
s1
r1
;
s3
r3
Another model assumption that we made was that the
relation between infection level and the CCA test result
is independent of the prevalence, this assumes that test
interactions only occur within an individual at any given
time, and thus we fitted one k1 and k2 parameter for all
three time-points. We also assumed a single over-
dispersion parameter ω across all time-points.
The model was run in a Bayesian framework using a
Gibbs sampling package in R [28] (“jags” [29] and “run-
jags” [30]), with two independent chains, a ‘burn-in’
period of 1000 iterations and 10,000 samples. Unin-
formative priors where used. Convergence was assessed
by visual examination of the trace plots and the
Gelman-Rubin statistic. The run includes all 364 individ-
uals, with up to six KK samples and one CCA value each
for every time-point, with the missing KK data inferred
by the model. We assessed the goodness-of-fit of the
model by comparing draws from the posterior distribu-
tion to the data, see Additional file 1.
Sampling from the model fit
After the model fitting, as described in the previous sec-
tion, we obtained a posterior distribution for each of the
fitted parameters (shapes and rates of the gamma distri-
bution at each time point, ω, k1 and k2 and PTr). We ex-
plored the relationship between the estimated true
prevalence and the average infection level, as prevalence
on average decreases at lower infection levels. This rela-
tionship is not linear, and we sampled without extrapo-
lating beyond the data, correlated values of average
infection level and prevalence, see Additional file 2.
These values are used to generate simulated populations,
and perform KK (two samples) and CCA tests on those
populations. We compared how KK and CCA preva-
lence changes as true prevalence varies. We also ex-
plored the error in the estimation of prevalence using
one to six KK and CCA, assuming trace results as either
positive (CCA+) or negative (CCA-).
Results
We compared prevalence estimations from the raw data
(either KK or CCA) with our model estimation of true
prevalence (Fig. 1). In general, both KK and CCA under-
estimate the prevalence of schistosomiasis in our popu-
lation compared to the model. It is important to note
that trace results in the CCA test can be either consid-
ered infected (Fig. 1; CCA+, green triangle) or unin-
fected (Fig. 1; CCA-, blue square). Using trace results in
the CCA as positive improves the estimation of preva-
lence over trace results as negative for S. mansoni in this
high endemicity community, and is a better estimator
than KK at all time points. We estimated the proportion
of truly uninfected individuals that have trace CCA re-
sults (rather than negative) to be around 15%, albeit our
credible interval ranges from 4 to 27%.
The posterior draws from the model fitting were used
to compare average estimated underlying intensity and
prevalence of infection in this community (Fig. 2). At
baseline before treatment, the estimated true prevalence
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was high, as expected, and so was the average intensity
of infection in the population (green area). One month
after treatment, both the prevalence and average inten-
sity of infection have drastically decreased (black area).
However, six months after treatment (blue area), preva-
lence levels were similar to pre-treatment values, but the
average intensity of infection was lower than at baseline,
and moderately higher than one month after treatment.
We then interpolated across a range of infection levels to
assess how the estimation of CCA and KK prevalence var-
ies as true prevalence changes (Fig. 3a), and the relationship
between both diagnostics (Fig. 3b). In Fig. 3a, the dotted di-
agonal indicates a diagnostic yielding the true prevalence,
with points under the diagonal underestimating true preva-
lence, while the opposite is true for the points above the di-
agonal. As true prevalence increases, the difference in the
prevalence estimation error between CCA and double KK
diagnostics decreases. Only at high prevalence levels, from
approximately over 70–80%, we see KK (Fig. 3; black) giv-
ing in general higher prevalence estimates (and therefore
closer to the true prevalence) than CCA assuming trace
readings as negative (Fig. 3; CCA-, blue). Whereas, if we
Fig. 1 Prevalence comparison between raw data and model prediction. Point estimates are the predicted values based on the raw data, black circles
represent estimated prevalences using Kato-Katz, while the green triangles and blue squares are the estimates using a circulating cathodic antigen
diagnostic, assuming trace results as positive (CCA+) and negative (CCA-), respectively. Red point with credible interval is the prevalence estimated by
the model. Individual diagnostics prevalence estimates are generally lower than model predicted values combining both diagnostics
Fig. 2 Posterior distribution of average intensity of infection vs true prevalence. Each colour represent a different time point. At baseline (green) both
prevalence and intensity of infection are high; one month post-treatment (black) both prevalence and infection are low; six months post-treatment
(blue) the prevalence is similar to baseline, but the average population intensity of infection is still relatively low. This suggests that prevalence recovers
faster in the population than intensity of infection, which builds up more slowly. The intensity of infection is shown in eggs per gram (epg) for clarity,
however, the raw data are used in the model
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consider a CCA trace reading as a positive result, CCA
diagnostics would generally underestimate true prevalence
above 85%, but will otherwise tend to overestimate preva-
lence at lower levels of true prevalence (Fig. 3; CCA+,
green). In Fig. 3b we can see the non-linear relationship
between both diagnostics. CCA+ diagnostics will rapidly
overestimate prevalence compared to KK as prevalence de-
creases (i.e. above the diagonal). On the other hand, CCA-
estimates only give higher estimated prevalences than KK
at low levels of prevalence, with both diagnostics underesti-
mating true prevalence (Fig. 3). We did not simulate values
below ∼35% true infection prevalence, as this was the lower
value of estimated true prevalence in our data, correspond-
ing to 1 month post-treatment (Fig. 3). It is important to
note that prevalence estimated with either CCA- or KK al-
ways underestimated true prevalence in our simulations.
In the simulated population, we also mimicked differ-
ent repeated KK test results, from one to six samples
(informed by the data) and compared the error in the es-
timation of true prevalence (Fig. 4). The error in true
prevalence estimation slightly decreased as more sam-
ples were examined by KK. However, CCA assuming
trace results as positive (Fig. 4; green) had the smallest
error in prevalence estimation, smaller than even six re-
peated KK. Of particular note is that using CCA but as-
suming trace readings were negative (Fig. 4; blue), had a
significantly larger error than even a single KK across
our simulated populations.
Discussion
We have performed an analysis to compare prevalence
estimates using one to six repeated KK and a single
CCA test, to understand how they differ from estimated
true prevalence values. This is particularly important as
current public health policy decisions are based on preva-
lence by KK [31], and the estimates obtained using CCA
are often higher and will have a different degree of bias.
Moreover, since CCA is now being used in some countries
to map schistosomiasis, it is crucial to understand how to
interpret these new results so that control strategies can
be updated accordingly and additional drug treatment re-
quests and production be set in motion [22].
Kato-Katz smears have historically been vital for diag-
nosis and policy decisions and remain extremely useful
at high levels of prevalence. This is because a high
prevalence is associated with an average high intensity of
infection. However, many highly endemic countries have
been implementing mass control programmes for over a
decade now and infection intensities in several regions,
but not all, are now lower. Low sensitivity of the diag-
nostic test at low infection levels is now becoming an
important issue. As shown in Fig. 1, the KK estimate of
prevalence is significantly lower six months post-
treatment than at baseline (∼10% lower estimate), even
though the estimated true prevalence is the same. This
a b
Fig. 3 Comparison between diagnostic estimates and true prevalence for simulated data. Colours represent the different diagnostics. Double KK
estimates are coloured black (circles), CCA with trace results as positives (CCA+) are represented by green triangles, while CCA with trace as negative
(CCA-) are blue squares. Symbols coloured red are the real data from the diagnostics for the average estimated true prevalence (Baseline and one and
six months post-treatment). a Comparison of the different diagnostics and true prevalence illustrating that KK and CCA- always underestimate true
prevalence, while CCA+ overestimates prevalence at low/medium prevalences. b Comparison of CCA diagnostics (CCA+ and CCA-) and KK diagnostics
(two samples) showing a non-linear relationship as prevalence changes
Fig. 4 Error in prevalence estimation based on simulated data. Mean
and standard deviation across all simulated points. Error decreases as the
number of repeated Kato-Katz measures increases but CCA assuming
trace as positive (CCA+) has an overall smaller error in prevalence
estimation. This suggests that multiple KK will improve precision, but not
enough compared to CCA+, particularly at low levels of prevalence
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becomes apparent when looking at the average intensity
of infection estimates which show much lower inten-
sities six months post-treatment (Fig. 2). CCA, on the
other hand, is generally a better estimator for true preva-
lence, particularly when assuming that trace results are
positive, although this will lead to overestimation of
prevalence at low true prevalences (Fig. 3a; green). This
could be in part because even if a proportion of the trace
results belong to uninfected individuals (we estimate it
to be 15% on average), at a population level it helps
minimize the underestimation of true prevalence inher-
ent in the diagnostic (Fig. 4).
The relationship between prevalence estimates from
CCA and KK as true prevalence changes is not linear
(Fig. 3b) and in general, CCA is a better estimator of preva-
lence, particularly at low prevalences. The relationship we
have estimated could be used to compare historical KK
prevalence estimates to more contemporary, often higher
CCA estimates. This is particularly helpful for programmes
which have switched from KK to CCA and need to make
informed public health decisions. However, it is still unclear
exactly how the intensity of infection and prevalence in-
creases after treatment over a short timescale, and more
time-points are needed between one and six months post-
treatment. In our approach we did not extrapolate beyond
our data and therefore assumed the correlation between
prevalence and intensity to be maintained.
It is also important to note that observing high preva-
lences (or even pre-treatment prevalence levels) a few
months after treatment does not necessarily mean that
intensities of infection are the same as before treatment
(Fig. 2). With KK, we would potentially estimate a lower
prevalence after treatment, because the average egg
count in the population will be lower. However, using
CCA as a diagnostic tool instead means that we would
recover a better estimation of prevalence (i.e. a high
prevalence), but we would miss the fact that the average
intensity of infection is in fact reduced. A biological justifi-
cation for this could be that praziquantel treatment has a
higher efficacy in adult schistosomes and a reduced effect
on juveniles [32, 33]. Therefore a few months after treat-
ment, we would expect to see the juveniles becoming
adults, but the overall infection load may still be low, due
to a lower schistosome adult populations and only six
months of new parasite exposure. This varying relationship
between diagnostic test and accuracy in detecting preva-
lence versus intensity is important because public health
guidelines for control are focused on prevalence data, whilst
morbidity is positively correlated with infection intensity.
Therefore, there is a potential disconnect between the
prevalence indicators which WHO use for treatment guide-
lines and the intensity indicators which the WHO have as
goals for morbidity control, with each of them also being
affected by the choice of diagnostic test.
Future genetic studies may help elucidate the origin of
the parasite eggs and/or antigens post-treatment, to
decipher whether antigens are from new infections or
surviving juveniles, which were not affected by the treat-
ment, or whether they are from adult worms surviving
the standard treatment and therefore resistant to the
currently used drug praziquantel. In addition, the true
meaning of a “trace” reading, and the absence of a “gold
standard”, may become more important after recent
praziquantel treatment than our current model can ex-
plain. Correlations held at low intensities pre-treatment
in low endemicity area, may not hold for similar low in-
tensities (measured by KKs) post-treatment. These two
situations, which may have similar mean eggs per gram
values measured by KKs alone could reflect vastly differ-
ent biological scenarios. Recent praziquantel treatment
may interact with parasite juvenile and adult worm
numbers, and egg production and clearance. All of these
factors, plus the rate of continued parasite exposure and
reinfection, strongly linked to endemicity and force of
infection, may affect egg and/or antigen excretion at fol-
low up. This in turn affects KK and/or CCA readings,
blurring any pre-treatment correlations between KK and
CCA outputs even further. This may in part explain why
point estimates in Fig. 1 are more tightly clustered be-
tween diagnostic techniques than post-treatment.
Conclusions
We have shown the relationship between the two most
commonly used diagnostic tools for S. mansoni infection,
an egg-based and an antigen-based diagnostic. Having mul-
tiple diagnostics for a particular disease is becoming more
common, but connecting the alternative diagnostics can
prove challenging. In neglected tropical diseases, new stud-
ies are being done in this scope, such as the work by Irvine
et al. [34] in lymphatic filariasis diagnostics. Understanding
the interactions between the different diagnostic tools is
important, particularly for diseases such as schistosomiasis
that have ambitious targets for control and elimination by
2020. This study improves our understanding of these in-
teractions and how to interpret prevalence and intensity
measures of S. mansoni infection pre- and post-treatment.
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